Compounds > 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid

4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid and Chlamydia Infections

4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid has been researched along with Chlamydia Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Imtiaz, MT; Kasimos, JN; Ramsey, KH; Schripsema, JH; Sigar, IM	1

Other Studies

1 other study(ies) available for 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid and Chlamydia Infections

Article	Year
Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection. Infection and immunity, 2006, Volume: 74, Issue:10 Topics: Animals; Captopril; Chlamydia Infections; Chlamydia muridarum; Chronic Disease; Female; Female Urogenital Diseases; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Mice; Mice, Mutant Strains; Oligopeptides; Tetracycline	2006

Article

Year

Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection.

Infection and immunity, 2006, Volume: 74, Issue:10

Topics: Animals; Captopril; Chlamydia Infections; Chlamydia muridarum; Chronic Disease; Female; Female Urogenital Diseases; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Mice; Mice, Mutant Strains; Oligopeptides; Tetracycline

2006